MariMed (OTCMKTS:MRMD) Announces Quarterly Earnings Results, Meets Expectations

MariMed (OTCMKTS:MRMD) announced its quarterly earnings results on Wednesday. The company reported ($0.01) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.01), Zacks reports. MariMed had a negative return on equity of 2.75% and a negative net margin of 10.97%.

MariMed Price Performance

MRMD stock traded up $0.00 during midday trading on Wednesday, reaching $0.12. 937,712 shares of the company’s stock traded hands, compared to its average volume of 404,236. The company has a 50-day simple moving average of $0.12 and a two-hundred day simple moving average of $0.15. The company has a quick ratio of 0.73, a current ratio of 1.55 and a debt-to-equity ratio of 1.01. MariMed has a 1-year low of $0.11 and a 1-year high of $0.34. The company has a market cap of $43.87 million, a price-to-earnings ratio of -2.88 and a beta of 2.69.

MariMed Company Profile

MariMed Inc engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand.